The most-read stories last month include proposed changes to the scheduling of melatonin and green tea extract in Australia, Nestle's novel infant formula launch in China, and product trends in anti-hyperpigmentation across Asia.
Australia's Therapeutic Goods Administration (TGA) has proposed changes to the scheduling of melatonin and green tea extract, with new dosage indications for the former and a completely new entry into the Poisons Standard for the latter.
A higher dietary intake of magnesium and potassium is linked with milder knee osteoarthritis (OA) symptoms, according to a two-year observational study that took place in Australia.
Nestle has introduced new infant formulas containing a novel nutrient blend in China, after the product made its global debut in Hong Kong in July.
Skin care firms are increasingly launching supplements that claim to reduce skin hyperpigmentation, giving consumers an alternative to traditional topical creams.
The drinking of twig tea was shown to lower fasting blood glucose to a greater extent than regular tea, according to a 12-week study conducted in Japan.
Danone China has added two low glycemic index milk formulas to its recently launched healthy ageing brand Ganmai.
Like several Asian countries, Thailand is experiencing a greying population. While interest in healthy ageing is high, the level of innovation for this category of products remains relatively low.
Bubs Australia is hoping to expand its presence in China via the general trade route through the introduction of its first China-label goat milk infant formula.
Less than half of the Health Functional Foods (HFF) reported to have caused adverse health events were recalled in South Korea between 2018 and June this year, according to official data.
South Korea's Ministry of Food and Drug Safety (MFDS) has begun a one-year long inspection order on specific probiotics products imported from North America and Denmark.
